文献速递脑血管病神经重症与神经感染

强化降压与快速出血性颅内出血患者血肿增长减少相关

Intensive Blood Pressure Reduction is Associated with Reduced Hematoma Growth in Fast Bleeding Intracerebral Hemorrhage.
PubMed 文献 · Ann Neurol · 2023-09-28

该研究为ATACH-2随机对照试验的探索性分析,纳入940例自发性颅内出血患者,其中567例符合快速出血定义(基线血肿体积/发病至CT时间>5 ml/hr)。在快速出血患者中,强化降压与血肿增长发生率显著降低相关(20.6% vs 31.0%,p=0.005);在发病2小时内治疗的亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69,p=0.031)。

要点

  • 快速出血定义为颅内出血体积与发病至CT时间之比>5 ml/hr,本研究567例(60.3%)符合。
  • 快速出血患者中,强化降压组血肿增长发生率20.6%,低于对照组的31.0%(p=0.005)。
  • 发病2小时内治疗的快速出血亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69)。

核心结论

  • 研究结果提示,早期使用强化降压可能减少快速出血患者的血肿增长并改善预后。

研究设计与样本

  • 对ATACH-2随机对照试验数据进行的探索性分析,共纳入940例患者(平均年龄62.1岁,61.5%为男性)。
  • 研究限定为快速出血性颅内出血,定义为颅内出血体积/发病至CT时间>5 ml/hr;血肿增长定义为基线至24小时血肿体积增加>33%。

主要发现

  • 940例患者中214例(22.8%)发生血肿增长;567例(60.3%)符合快速出血定义,其基线颅内出血体积与就诊时间之比至少为5 ml/hr。
  • 在快速出血患者中,强化降压与血肿增长率显著降低相关(20.6% vs 31.0%,p=0.005)。
  • 在发病2小时内接受治疗的266例(46.9%)快速出血患者亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69,p=0.031)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with spontaneous intracerebral hemorrhage (ICH) at the highest risk of hematoma growth are those with the most potential to benefit from anti-expansion treatment. Large clinical trials have not definitively shown a clear benefit of blood pressure (BP) reduction. We aim to determine whether intensive blood pressure reduction could benefit patients with fast bleeding ICH. METHODS: An exploratory analysis of data from the Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 (ATACH-2) randomized controlled trial was performed. In order to capture not just early bleeding (even if a small amount), but the rate of bleeding (ml/hour), we restricted the study to "Fast bleeding ICH," defined as an ICH volume/onset to computed tomography (CT) time >5 ml/hr. Hematoma growth, as defined as an increase of hematoma volume > 33% between baseline and 24 hours. RESULTS: A total of 940 patients were included (mean age = 62.1 years, 61.5% men), of whom 214 (22.8%) experienced hematoma expansion. Of these, 567 (60.3%) met the definition of "fast bleeding" with baseline ICH volume/time to presentation of at least 5 ml/hr. Intensive BP reduction was associated with a significantly lower rate of hematoma growth in fast bleeding patients (20.6% vs 31.0%, p = 0.005). In a subgroup of 266 (46.9%) fast-bleeding patients who received treatment within 2 hours after symptom onset, intensive BP lowering was associated with improved functional independence (odds ratio [OR] = 1.98, 95% confidence interval [CI] = 1.06-3.69, p = 0.031). INTERPRETATION: Our results suggest that early use of intensive BP reduction may reduce hematoma growth and improve outcome in fast bleeding patients. ANN NEUROL 2024;95:129-136.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Li Q, Morotti A, Warren A, et al. Intensive Blood Pressure Reduction is Associated with Reduced Hematoma Growth in Fast Bleeding Intracerebral Hemorrhage. Ann Neurol. 2023. PMID: 37706569. doi:10.1002/ana.26795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。